Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Sema4 Appoints Health IT Industry Leader Jamie Coffin as President and Chief Operating Officer

Sema4
Posted on: 03 Oct 17

Sema4, a health information company providing advanced genomic testing, today announced the appointment of Jamie Coffin, Ph.D., as President and Chief Operating Officer. Dr. Coffin has been a leader for more than 20 years within the health information technology (IT) sector, with a background including transforming Dell into the top health IT business in the world and leading the team that grew IBM’s healthcare and life sciences division to a market leader.

“Jamie has an extensive background of leadership in the healthcare and life sciences sector and a tremendous track record of success at building top health IT services businesses,” said Eric Schadt, Ph.D., Chief Executive Officer of Sema4. “Jamie brings to Sema4 the exact skills we need to rapidly scale and expand our business nationwide and achieve our vision of helping patients, clinicians, and researchers to better diagnose, treat, and prevent disease. I am very pleased to welcome him to the Sema4 team.”

“I look forward to helping Sema4 achieve its tremendous potential to transform the clinical diagnostics market by merging big data analytics with advanced genomic testing,” said Dr. Coffin. “We have a remarkable opportunity to improve consumers’ lives by delivering more useful, predictive, and reliable information to guide healthcare than has ever been possible before.”

Prior to joining Sema4, Dr. Coffin was the CEO of Source Medical Solutions, Inc., the top provider of practice management and electronic medical record solutions for the ambulatory surgical space. As Worldwide Vice President, General Manager, and Global Practice Lead at Dell’s Healthcare and Life Sciences group, he pioneered efforts to apply leading-edge IT into areas including EMR, data analytics, high performance and cloud computing, personalized medicine, genomics and proteomics, claims processing, medical imaging, and pharmaceutical and biotech drug discovery. His efforts drove Dell from a small player in healthcare to the top healthcare IT company in the world. He began his career at IBM, where he held a number of positions of increasing responsibility, ultimately becoming Worldwide Vice President of IBM Healthcare and Life Sciences. Dr. Coffin holds a Ph.D. in computational chemistry from the University of Arkansas.

About Sema4

Sema4 is a next generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics. Our team is creating practical tools that help patients, clinicians, and researchers better diagnose, treat, and prevent disease.

Sema4 is constructing a more comprehensive picture of health by combining a wealth of clinical experience that informs the answers that patients and providers are seeking, the world-class academic research that illuminates new directions, and the pioneering information science that puts all the pieces together.

For more information, please visit sema4genomics.com and connect with Sema4 on FacebookTwitter and YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170926005560/en/

Business Wire
www.businesswire.com

Last updated on: 03/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.